Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
23 hedge funds and large institutions have $3.76M invested in Biostage, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.
18% less funds holding
Funds holding: 28 → 23 (-5)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
30% less capital invested
Capital invested by funds: $5.38M → $3.76M (-$1.62M)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$29.9K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.59K |
| 3 |
Goldman Sachs
New York
|
+$4.23K |
| 4 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$2.49K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$501K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$141K |
| 3 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$138K |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$24K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$17K |
BSTG Hedge Fund Activity: Q1 2016 in Review
23 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q1 2016, worth a combined $3.76M — down 30% from $5.38M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BSTG and 2 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $29.9K. The largest seller was State of New Jersey Common Pension Fund D, exiting entirely with an estimated $501K sold.
- 23 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q1 2016, down from 28 in Q4 2015.
- Funds reported $3.76M of Biostage, Inc. Common Stock stock for Q1 2016, down 30% quarter-over-quarter.
- 2 funds opened new Biostage, Inc. Common Stock positions in Q1 2016 and 7 closed out, a net change of -5 holders.
- The largest Biostage, Inc. Common Stock buyer in Q1 2016 was Citadel Advisors, an estimated $29.9K added.
- The largest Biostage, Inc. Common Stock seller in Q1 2016 was State of New Jersey Common Pension Fund D, an estimated $501K sold.
Based on aggregated 13F filings for Q1 2016.